万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://cancerci.biomedcentral.com/
https://link.springer.com/journal/12935/volumes-and-issues
3、投稿网址：
https://submission.nature.com/new-submission/12935/3
4、期刊刊期：年刊，一年出版1期。
2022年1月11日星期二
投稿须知【官网信息】
Cancer Cell International
Submission guidelines
Our 3-step submission process
Before you submit
Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit.
Make sure you are submitting to the most suitable journal - Aims and scope
Understand the costs and funding options - Fees and funding
Make sure your manuscript is accurate and readable - Language editing services
Understand the copyright agreement - Copyright
Ready to submit
To give your manuscript the best chance of publication, follow these policies and formatting guidelines.
General formatting rules for all article types - Preparing your manuscript
Make sure your submission is complete - Prepare supporting information
Copyright and license agreement - Conditions of publication
Read and agree to our Editorial Policies - Editorial policies
Submit and promote
After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond.
Please note that manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.
Who decides whether my work will be accepted? - Peer-review policy
Want to submit to a different journal? - Manuscript transfers
Spreading the word - Promoting your publication
Submit manuscript
Aims and scope
Cancer Cell International publishes articles on all aspects of cancer cell biology originating from work using laboratory experimentation.
The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments). These types of experiments have provided crucial data in many fields, from cell proliferation and transformation, to epithelial-mesenchymal interaction, to apoptosis, and host immune response to tumors.
Cancer Cell International also considers articles that focus on novel technologies or novel pathways in molecular analysis and on epidemiological studies that may affect patient care, as well as articles reporting translational cancer research studies where in vitro discoveries are bridged to the clinic. As such, the journal is interested in laboratory and animal studies reporting on novel biomarkers of tumor progression and response to therapy and on their applicability to human cancers.
Fees and funding
Article-processing charges
Open access publishing is not without costs. Cancer Cell International therefore levies an article-processing charge of £1990.00/$2790.00/€2290.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs.
Springer Nature offers agreements that enable institutions to cover open access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included.
For more information on APCs please see our Journal Pricing FAQs
……
更多详情：
https://cancerci.biomedcentral.com/submission-guidelines
